Potential New Product definition

Potential New Product means any protein(s) or peptide(s) (other than G2H7) [CONFIDENTIAL TREATMENT REQUESTED], and such protein(s) or peptide(s):
Sample 1Sample 2Sample 3
Potential New Product means any protein(s) or peptide(s) (other than G2H7) [*], and such protein(s) or peptide(s): (a) was (were) acquired by [*] from a Third Party [*] (such Potential New Product a [*] Potential New Product”); or (b) was (were) acquired by [*] from a Third Party [*] (such Potential New Product a [*] Potential New Product”) (collectively, [*] Potential New Products and [*] Potential New Products may be referred to herein as “[*] Potential New Products”); or (c) was (were) developed by Genentech (including any protein(s) or peptide(s) acquired by [*] (such Potential New Product a [*] Potential New Product”)).
Sample 1
Potential New Product means any protein(s) or peptide(s) (other than G2H7) [CONFIDENTIAL TREATMENT REQUESTED], and such protein(s) or peptide(s): (a) [CONFIDENTIAL TREATMENT REQUESTED] (such Potential New Product a “[CONFIDENTIAL TREATMENT REQUESTED] Potential New Product”); or (b) [CONFIDENTIAL TREATMENT REQUESTED] (such Potential New Product a “[CONFIDENTIAL TREATMENT REQUESTED] Potential New Product”) (collectively, [CONFIDENTIAL TREATMENT REQUESTED] Potential New Products and [CONFIDENTIAL TREATMENT REQUESTED] Potential New Products may be referred to herein as “[CONFIDENTIAL TREATMENT REQUESTED] Potential New Products”); or (c) was (were) developed by Genentech (including any protein(s) or peptide(s) [CONFIDENTIAL TREATMENT REQUESTED] (such Potential New Product a “[CONFIDENTIAL TREATMENT REQUESTED] Potential New Product”)).
Sample 1

Examples of Potential New Product in a sentence

  • IDEC shall have sixty (60) days from the date of Genentech’s notice to IDEC of the availability of a Potential New Product to provide written notice to Genentech that it elects to participate in the development and commercialization of such Potential New Product.

  • Costs incurred with respect to a Potential New Product prior to the time such product becomes a New Product under the Collaboration Agreement are not chargeable to GenIDEC.

  • Within ten (10) days following an election to participate in a Genentech Potential New Product, IDEC shall pay Genentech the opt-in fee set forth in Section 7.1(b)(ii) or (iii), as the case may be.

  • For a period of thirty (30) days following an election by IDEC to participate in an [CONFIDENTIAL TREATMENT REQUESTED] Potential New Product, Genentech and IDEC shall use good faith efforts to agree upon the amount of the opt-in fee IDEC shall pay in order to obtain the right to include such [CONFIDENTIAL TREATMENT REQUESTED] Potential New Product as a New Product hereunder; such amount to be [CONFIDENTIAL TREATMENT REQUESTED] cost of such product attributable to rights in the United States.

  • The economic efficiency at appraisal focused on the benefits from the Central American countries pooling risks.This analysis showed that Honduras and Nicaragua could reduce the cost of catastrophic risk insurance by 27 percent or 41 percent when transferring catastrophic risk with other Council of Ministers of Finance of Central America and Dominican Republic (COSEFIN) countries.

  • Genentech shall pay IDEC a [CONFIDENTIAL TREATMENT REQUESTED] royalty on Royalty-Bearing Sales in the Licensed Territory of G2H7 and each other New Product; provided however, that no such royalty shall be due on any [CONFIDENTIAL TREATMENT REQUESTED] Potential New Product that was deemed a New Product pursuant to Section 2.5(b)(ii), nor on any Third Party Anti-CD20 Product for which IDEC enters into a written agreement with Genentech pursuant to Section 2.6.

  • IDEC shall have sixty (60) days from the date of Genentech's notice to IDEC of the availability of a Potential New Product to provide written notice to Genentech that it elects to participate in the development and commercialization of such Potential New Product.

  • From and after the date of the payment of such fee, such [CONFIDENTIAL TREATMENT REQUESTED] Potential New Product shall be deemed a New Product under this Agreement, and the Parties shall [CONFIDENTIAL TREATMENT REQUESTED].

  • With respect to [CONFIDENTIAL TREATMENT REQUESTED] Potential New Products, [CONFIDENTIAL TREATMENT REQUESTED], Genentech will provide to IDEC a summary of Genentech’s rights (and IDEC’s potential rights) to develop and commercialize such [CONFIDENTIAL TREATMENT REQUESTED] Potential New Product, as well as relevant information about the product, including preclinical and clinical data and reports [CONFIDENTIAL TREATMENT REQUESTED].

  • Within ten (10) days following an election to participate in a [CONFIDENTIAL TREATMENT REQUESTED] Potential New Product, IDEC shall pay Genentech the opt-in fee set forth in Section 7.1(b)(ii) or (iii), as the case may be.


More Definitions of Potential New Product

Potential New Product means any protein(s) or peptide(s) (other than G2H7) [CONFIDENTIAL TREATMENT REQUESTED], and such protein(s) or peptide(s): (a) was (were) acquired by [CONFIDENTIAL TREATMENT REQUESTED] from a Third Party [CONFIDENTIAL TREATMENT REQUESTED] (such Potential New Product a "[CONFIDENTIAL TREATMENT REQUESTED] Potential New Product"); or (b) was (were) acquired by [CONFIDENTIAL TREATMENT REQUESTED] from a Third Party [CONFIDENTIAL TREATMENT REQUESTED] (such Potential New Product a "[CONFIDENTIAL TREATMENT REQUESTED] Potential New Product") (collectively, [CONFIDENTIAL TREATMENT REQUESTED] Potential New Products and [CONFIDENTIAL TREATMENT REQUESTED] Potential New Products may be referred to herein as "[CONFIDENTIAL TREATMENT REQUESTED] Potential New Products"); or (c) was (were) developed by Genentech (including any protein(s) or peptide(s) acquired by [CONFIDENTIAL TREATMENT REQUESTED] (such Potential New Product a "[CONFIDENTIAL TREATMENT REQUESTED] Potential New Product")).
Sample 1

Related to Potential New Product

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Licensed Compound means [***].

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Biosimilar Product means, with respect to a Licensed Product and on a country-by-country basis, a product that [***].

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • New Products means any product which is not an Enhanced Product or 2 Existing Product but which is substantially similar to an Existing Product with respect to design and function and possesses reasonable performance improvements. If Company desires to purchase an Enhanced or New Product(s) from Supplier, Company shall so notify Supplier and provide Supplier the opportunity to manufacture such Enhanced or New Product(s), subject to the following conditions and procedures.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Licensed Field means [***].

  • Additional Indication means any indication other than the Initial Indication.

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.

  • Edible cannabis product means cannabis product that is intended to be used, in whole or in part, for human consumption, including, but not limited to, chewing gum, but excluding products set forth in Division 15 (commencing with Section 32501) of the Food and Agricultural Code. An edible cannabis product is not considered food, as defined by Section 109935 of the Health and Safety Code, or a drug, as defined by Section 109925 of the Health and Safety Code.

  • Covered Product The consumer product that You purchased concurrently with and is covered by this Agreement.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Pharmaceutical Product shall have the meaning ascribed to such term in Section 3.1(hh).

  • Competing Product means [***].

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • Initial Indication means the use of a Product for the treatment of opioid addiction.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Cannabis product means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.